The Behavioral/Social Sciences and Community Outreach (BSSCO) Core will work with the CFAR Cores to support the aims of the Miami CFAR. Specifically, the BSSCO core will support the development of new HIV investigators, research initiatives, and collaborations among University of Miami (UM) behavioral/social, clinical, and laboratory scientists. The BSSCO Core will assist CFAR investigators in establishing and maintaining strong and bi-directional community partnerships. The core services will build on the expertise, experience and existing research programs of our interdisciplinary BSSCO leadership as well as the strengths of the UM researchers and the previous successes in the DCFAR.
The aims of the BSSCO Core are as follows: 1) Promote active involvement of South Florida community based organizations (CBOs) in the Miami CFAR, by expanding the Community Advisory Board (CAB) that was developed under the DCFAR, and by ensuring that the CAB has input in the development, implementation, monitoring, completion, and translation of research projects;2) Provide investigators with consultation and resources to enhance recruitment and retention of community and clinic-based study participants with attention to "hard to find" populations, including MSM, sex workers, illicit drug users, and those not in HIV care;3) Expand the opportunities for behavioral/social scientists to collaborate with clinical and laboratory scientists, providing consultation to assist CFAR investigators as they integrate biological measures into behavioral/social science studies, providing assistance with obtaining biological samples from cohort studies and with the development of interdisciplinary grant applications.
The BSSCO core will enhance and expand existing research programs, promote new interdisciplinary research initiatives, and provide the infrastructure necessary to enable CFAR researchers to strategically move into new, high priority areas of investigation. This core will also establish and maintain beneficial bidirectional partnerships with community-based and AIDS service organizations.
|Thomas, Emmanuel; Liang, T Jake (2016) Experimental models of hepatitis B and C - new insights and progress. Nat Rev Gastroenterol Hepatol 13:362-74|
|Metsch, Lisa R; Feaster, Daniel J; Gooden, Lauren et al. (2016) Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial. JAMA 316:156-70|
|Liu, Albert Y; Cohen, Stephanie E; Vittinghoff, Eric et al. (2016) Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services. JAMA Intern Med 176:75-84|
|Kim, Ahrom; Han, Li; Santiago, Gabriel E et al. (2016) Class-Switch Recombination in the Absence of the IgH 3' Regulatory Region. J Immunol 197:2930-5|
|Verma, Shefali S; Frase, Alex T; Verma, Anurag et al. (2016) PHENOME-WIDE INTERACTION STUDY (PheWIS) IN AIDS CLINICAL TRIALS GROUP DATA (ACTG). Pac Symp Biocomput 21:57-68|
|Echenique, Marisa; Rodriguez, Violeta J; LaCabe, Richard P et al. (2016) Behaviorally and perinatally HIV-infected young women: targets for preconception counseling. AIDS Care :1-6|
|Peltzer, Karl; Rodriguez, Violeta J; Jones, Deborah (2016) Prevalence of prenatal depression and associated factors among HIV-positive women in primary care in Mpumalanga province, South Africa. SAHARA J 13:60-7|
|Cortizas, Elena M; Zahn, Astrid; Safavi, Shiva et al. (2016) UNG protects B cells from AID-induced telomere loss. J Exp Med 213:2459-2472|
|Strbo, Natasa; Alcaide, Maria L; Romero, Laura et al. (2016) Loss of Intra-Epithelial Endocervical Gamma Delta (GD) 1 T Cells in HIV-Infected Women. Am J Reprod Immunol 75:134-45|
|Pinto, Milena; Nissanka, Nadee; Peralta, Susana et al. (2016) Pioglitazone ameliorates the phenotype of a novel Parkinson's disease mouse model by reducing neuroinflammation. Mol Neurodegener 11:25|
Showing the most recent 10 out of 243 publications